Meet us at the GCI Virtual Summit as we gather with important voices in cannabis insights leadership to hear their perspectives and engage in data storytelling as regulations and innovation advance the state of cannabis research around the world.
The GCI Summit gives global leaders the opportunity to network with the best minds in cannabis and psychedelics on 8-10 June, 2021. Featuring thought leaders from around the globe, the GCI Summit presents a unique experience for participating leaders across seven virtual topic areas.
RESEARCH & APPLIED SCIENCE | MEDICINE, TREATMENT & PATIENTS | PSYCHEDELICS | REGULATIONS & INTERNATIONAL MARKETS | CONSUMER BRANDS & RETAIL | INVESTMENT & FINANCE | CULTIVATION, OPS & TECH
SNAPSHOT OF THOUGHT LEADERS
You can hear from and network with global cannabis and psychedelics industry heavyweights, such as:
- Kyle Detwiler, CEO, Clever Leaves
- Chris Webber, 5-Time NBA All-Star & Founder, Webber Wellness
- Narbe Alexandrian, President & CEO, RIV Capital
- Ronan Levy, Founder & Executive Chairman, Field Trip
- Jim Hourigan, CEO, CannaCraft
- Jeremy Berke, Senior Reporter, Business Insider
- Allison Krongard, Co-Founder, Her Highness
- Dr. Jeffrey Becker, Chief Scientific Officer, Bexson Biomedical
- Dr. Mikael Sodergren, Managing Director, Sapphire Medical Clinics
- Mitchell Baruchowitz, Managing Partner, Merida Capital Partners
- Crispin Blunt, Member of Parliament, House of Commons
- Dr. Dedi Meiri, Head of Lab for Cancer Biology & Cannabinoid Research, Technion
- Natalie Papillion, Director of Strategic Initiatives, The Last Prisoner Project
- Dr. Ethan Russo, Founder & CEO, CReDO Science
- Axel Bernabe, Assistant Counsel to NY State Governor Cuomo for Health, New York State Executive Chamber
- Benedikt Sons, Co-Founder & CEO, Cansativa
- Mara Gordon, Founder, Aunt Zelda’s
- Bruce Linton, Psychedelics & Cannabis Founder
- Georg Wurth, Director & Lobbyist, German Cannabis Association (Deutscher Hanfverband)
- Dr Jeremy Riggle, Chief Scientific Officer, Mary’s Medicinals
- Dr. Sandra Carrillo, President, Colombian Medical Cannabis Association
- Paul North, Director, Volteface
- Jason Wild, President & Chief Investment Officer, JW Asset Management
- Adam Grossman, Founder & Executive Chairman, Papa & Barkley
- Jared Mirsky, CEO, Wick & Mortar
- Ivo Bucaresky, Former Managing Director, ANVISA
- Professor Hinanit Koltai, Head of Cannabis Research Lab, Volcani Center
- Karim Webb, CEO, 4thMVMT
- Carlos Tanner, Director, Ayahuasca Foundation
- David Badcock, CEO, DrugScience
- Holly Bell, Director of Cannabis, Florida Department of Agriculture and Consumer Services
- Dr. Bruce Bugbee, Professor, Utah State University
View some of our founder’s older articles on cannabis research insights below citing some data from Vividata in Canada but also other sources outside Canada.
The Growth Op. Postmedia Group. Canada
Future of Ontario pot shops predicted to mirror Walmart and Costco, Canada
